<DOC>
	<DOCNO>NCT00562458</DOCNO>
	<brief_summary>To evaluate Arimidex 6 month therapy adjuvant treatment postmenopausal patient advance breast cancer partial complete response stabilize disease obtain first line chemotherapy , tumoral response assessment .</brief_summary>
	<brief_title>Non-interventional Study Evaluate Arimidex Postmenopausal Women With Advanced Breast Cancer</brief_title>
	<detailed_description />
	<mesh_term>Breast Neoplasms</mesh_term>
	<mesh_term>Anastrozole</mesh_term>
	<criteria>Patients include program one accord indication specify Romanian anastrozole ( Arimidex ) approve SmPC ( attach protocol ) already treat anastrozole least 1 month inclusion program/noninterventional study . Patients include programme : patient know hypersensitivity anastrozole ( ArimidexÂ® ) excipients .</criteria>
	<gender>Female</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2013</verification_date>
	<keyword>Advanced breast cancer</keyword>
	<keyword>Advanced breast cancer postmenopausal woman</keyword>
</DOC>